BiotechBlog Guest Content

BiotechBlog Opportunities are available for informative, non-commercial messages. The submission guidelines are at http://www.biotechblog.com/spread-your-message-with-biotechblog , and you can see existing guest content at http://www.biotechblog.com/category/guest-content/ .

You can email submissions directly to me for posting. Please include a author headshot/company logo and author/company bio for the byline along with any submissions.

Other publishing opportunities are also available in the Journal of Commercial Biotechnology and in books. See the publishing opportunities page for more details

Top 4 Healthcare Predictions for 2010

December 15, 2009

This is a guest post from Cliff Cramer, Director of the Healthcare and Pharmaceutical Management Program at Columbia Business School. Do you have a response to Cramer’s post? Post them in the comments section below. Multi-national pharmaceutical and medical technology companies will increase their investments in emerging markets, notably China and India, to access cost [...]

Read the full article →

India, Intellectual Property and Biotechnology Industry

December 3, 2009

This is a guest post from BiotechBlog reader Viren Konde. Do you have a response to Viren’s post? If so, you may respond in the comments section below. The recent editorial on “Intellectual property and biotechnology innovation: To protect or not protect” by Dr Yali Friedman, Managing Editor of the Journal of Commercial Biotechnology was [...]

Read the full article →

Pfizer’s Power on Individualized Medicine

September 15, 2009

In these videos Pfizer’s Vice President and Global Head of Molecular Medicine, Aidan Power, talk about a future where everyone’s genome is sequenced and drug prescriptions are based on your genetic makeup, and argues that personalized medicine will be the defining paradigm for discovering and developing drugs of the future. To put these videos into [...]

Read the full article →

Naturally Obsessed: The Making of a Scientist

July 27, 2009

Guest content from Naturally Obsessed Naturally Obsessed: The Making of a Scientist A documentary about careers in science “So what is it that you actually do, Dr. Rifkind?” (groan, groan) It didn’t matter if the question was from my accountant, my dinner party companion or my cousin Minnie, I was never able to give an [...]

Read the full article →

Koronis: Developing a new treatment for HIV

June 3, 2009

I recently had the opportunity to conduct a brief interview with Jeff Parkins, Vice President of Clinical Development and Regulatory at Koronis on his company and the future of the biotechnology industry: Can you tell me a little bit about Koronis and its mission? Koronis Pharmaceuticals develops anti-viral therapeutics based on Viral Decay Acceleration TM [...]

Read the full article →

Biotechnology Management Papers

May 27, 2009

These papers are from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons biotechnology company management: Financial opportunities for early stage biotech companies Tamara Jones The [...]

Read the full article →

The changing roles of CRO

May 27, 2009

This is a student paper from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. The changing roles of CRO Alex Bao [...]

Read the full article →

Discovering potential drug targets

May 27, 2009

This is a student paper from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. Discovering potential drug targets Myung K. Kim [...]

Read the full article →

Financial opportunities for early stage biotech companies

May 27, 2009

This is a student paper from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. Financial opportunities for early stage biotech companies [...]

Read the full article →

Solving the FDA Crisis

February 5, 2009

Guest content from John Avellanet, managing director and principal of Cerulean Associates: Solving the FDA Crisis By John Avellanet, Managing Director and Principal of Cerulean Associates LLC News of the latest crisis under the FDA’s watch – salmonella contamination and the peanut plant in Georgia – has all the usual suspects calling for increased inspections [...]

Read the full article →

← Previous Entries

Next Entries →